Evidence map›Paper›PMID 41098718›Full record

ArticleFrontiers in immunology2025

NLR (neutrophil to lymphocyte ratio), PLR (platelet to lymphocyte ratio), and SII (systemic immune-inflammation index) reflect disease activity and renal remission in patients with lupus nephritis.

Xiaohui Zhang, Yuan Chen, Yong Fan, Dai Gao, Zhuoli Zhang

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07780045 (Emerging Inflammatory Biomarkers), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07780045 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Emerging Inflammatory Biomarkers (SII and SIRI) for Predicting Disease Activity, Renal Flares and Outcomes in Lupus Nephritis: A Prospective Observational Study

Typeobservational_patient_registrySponsorAssiut UniversityRan2026 to 2027Enrolled100ConditionsLupus Nephritis, Systemic Lupus Erythematosus, Kidney Diseases
3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaohui ZhangDepartment of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
Yuan ChenDepartment of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
Yong FanDepartment of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
Dai GaoDepartment of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
Zhuoli ZhangDepartment of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the value of NLR (neutrophil to lymphocyte ratio), PLR (platelet to lymphocyte ratio), and SII (systemic immune-inflammation index) in reflecting disease activity and induction therapy remission in patients with lupus nephritis (LN). Methods: Active LN patients from STAR cohort were enrolled. We analyzed the trends of complete blood count parameters with Generalized Estimated Equation. Bivariate correlation analyses, Chi-square tests, Results: 310 active LN patients were enrolled in the study. All patients had active lupus with SLEDAI-2K 17.1 ± 6.1, median 24h-Urine Protein (UTP) level of 3.1 (1.5, 5.4) g. During the 12-month follow-up of induction therapy, NLR and PLR showed a decreasing trend. Both baseline NLR and SII were positively correlated with baseline UTP and serum creatinine (SCr) levels ( Conclusion: Our findings suggested that NLR and SII were valuable indicators of disease activity in LN, correlating with UTP, SCr and AI score of renal pathology. NLR, PLR and SII provided us a quick, simple and cost-effective supervision way in monitoring and managing LN patients.

Indexed as

Blood PlateletsLupus NephritisLymphocytesNeutrophilsAdultBiomarkersFemaleHumansInflammationLymphocyte CountMaleMiddle AgedPlatelet CountPrognosisRemission InductionSeverity of Illness IndexBiomarkersdisease activitylupus nephritisneutrophil to lymphocyte ratioplatelet to lymphocyte ratiorenal remissionsystemic immune-inflammation index

Identifiers

PMID41098718
PMCPMC12518351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.